LBPH insider transactions
Longboard Pharmaceuticals Inc. (LBPH) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for LBPH
- SEC Form 4 filed by Director Lynch Casey4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Director Le Goff Corinne4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Director Sekhri Paul J4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Director Schneider Phillip M4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Director Aurentz Vincent4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- Executive Vice President & CMO Kaye Randall closing all direct ownership in the company (SEC Form 4)4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Executive VP and CFO Roberts Brandi4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- President and CEO Lind Kevin Robert closing all direct ownership in the company (SEC Form 4)4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- CMO Kaye Randall exercised 30,554 shares at a strike of $6.00, increasing direct ownership by 171% to 48,474 units (SEC Form 4)4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- CEO Lind Kevin Robert exercised 12,808 shares at a strike of $3.12 and gifted 80,000 shares, decreasing direct ownership by 16% to 363,740 units (SEC Form 4)4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by CMO Kaye Randall4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by CFO Roberts Brandi4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by CEO Lind Kevin Robert4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- CMO Kaye Randall exercised 16,667 shares at a strike of $4.35 and sold $983,936 worth of shares (16,667 units at $59.03) (SEC Form 4)4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- CMO Kaye Randall exercised 16,666 shares at a strike of $4.35 and sold $527,318 worth of shares (16,666 units at $31.64) (SEC Form 4)4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- CEO Lind Kevin Robert exercised 82,482 shares at a strike of $3.15, increasing direct ownership by 24% to 430,932 units (SEC Form 4)4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- CMO Kaye Randall bought $2,482 worth of shares (100 units at $24.82), sold $580,891 worth of shares (16,767 units at $34.64) and exercised 16,667 shares at a strike of $4.35 (SEC Form 4)4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Sekhri Paul J4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Schneider Phillip M4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Lynch Casey4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Le Goff Corinne4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Aurentz Vincent4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- Kaye Randall was granted 17,920 shares (SEC Form 4)4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- Roberts Brandi was granted 15,090 shares (SEC Form 4)4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Lind Kevin Robert4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- Arena Pharmaceuticals Inc sold $96,479,595 worth of Voting Common Stock (3,978,540 units at $24.25), closing all direct ownership in the company (SEC Form 4)4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Sekhri Paul J4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Tiller Jane4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Aurentz Vincent4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Lynch Casey4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Schneider Phillip M4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Le Goff Corinne4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Roberts Brandi4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Kaye Randall4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Lind Kevin Robert4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Tiller Jane4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Sekhri Paul J4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Schneider Phillip M4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Lynch Casey4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Le Goff Corinne4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Aurentz Vincent4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Kaye Randall4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 3 filed by new insider Kaye Randall3 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Lind Kevin Robert4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Roberts Brandi4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Perera Philip4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Tiller Jane4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 3 filed by new insider Tiller Jane3 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
- SEC Form 4 filed by Aurentz Vincent4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)